Cafepharma Today

May 21 2025 - Medtronic plans to separate its diabetes business into a new company
Medtronic plans to separate its diabetes business into a new company
Moderna shares down after pulling Covid-flu combo vaccine application
Roche's Genentech sticks with Orionis in 2nd molecular glue deal worth $2B
RFK Jr. takes fire in Senate hearing on research cuts
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vertex discontinues AAV research for gene therapies
Fierce Biotech
Sunday, May 4, 2025 - 12:06pm
tags:
Vertex Pharmaceuticals, AAV gene therapy, gene therapy
AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion
Fierce Pharma
Sunday, May 4, 2025 - 12:05pm
tags:
AstraZeneca, Breztri Aerosphere, asthma, clinical trials
Under Trump Administration, Continued Full Coverage Of HIV PrEP Drugs Uncertain
Forbes
Sunday, May 4, 2025 - 12:03pm
tags:
HIV, PrEP, Donald Trump, Supreme Court
US FDA asks some fired pharma user fee negotiation staff to return
MSN/Reuters
Sunday, May 4, 2025 - 12:02pm
tags:
FDA, layoffs, user fees
Amgen’s Stelara biosimilar gets off to fast start
BioPharma Dive
Sunday, May 4, 2025 - 12:00pm
tags:
Amgen, Stelara, biosimilars, JNJ
Low-price drug nations catching ‘free ride’ on US innovation, report says
BioSpace
Friday, May 2, 2025 - 11:37am
tags:
drug pricing, innovation, Canada, Germany
UK unveils £1B plan to become leading cancer research hub just outside the Golden Triangle
Fierce Biotech
Friday, May 2, 2025 - 11:19am
tags:
London, UK, R&D, cancer
FDA frees Amgen's phase 1 obesity asset from clinical trial hold
Fierce Biotech
Friday, May 2, 2025 - 11:18am
tags:
FDA, Amgen, obesity, clinical trials, AMG 513
Amgen posts profit, says tax policy more effective than tariffs
Investing.com
Friday, May 2, 2025 - 10:55am
tags:
Amgen, earnings, tariffs
Intuitive earns expanded FDA nod for da Vinci single port system
Mass Device
Friday, May 2, 2025 - 10:53am
tags:
Medtech, Intuitive Surgical, FDA, da Vinci single port, robotic surgery
AstraZeneca’s triple-combo triumphs in two Phase III asthma trials
Clinical Trials Arena
Friday, May 2, 2025 - 10:50am
tags:
AstraZeneca, Breztri Aerosphere, asthma, clinical trials
Is pharma ready to let go of animal testing?
Pharma Voice
Friday, May 2, 2025 - 10:49am
tags:
animal testing, R&D, NIH
Design Therapeutics reports positive outcomes from trial of DT-168 eye drops
Clinical Trials Arena
Friday, May 2, 2025 - 10:49am
tags:
Design Therapeutics, DT-168, clinical trials, FECD
FDA delays decision date on Cytokinetics' heart drug to year-end in unusual safety program back-and-forth
Fierce Biotech
Friday, May 2, 2025 - 10:47am
tags:
Cytokinetics, aficamten, FDA, obstructive hypertrophic cardiomyopathy
FDA resurrects Satsuma's nasal migraine treatment
Pharmaphorum
Friday, May 2, 2025 - 10:44am
tags:
Satsuma Pharmaceuticals, FDA, Atzumi, migraines
Government cuts could help spark surge in M&A activity
Fierce Pharma
Friday, May 2, 2025 - 10:43am
tags:
M&A, Donald Trump, FTC, layoffs
WHO set to back use of weight-loss drugs for adults globally, raises cost issue
MSN/Reuters
Thursday, May 1, 2025 - 10:28pm
tags:
WHO, weight loss, obesity, Novo Nordisk, Eli Lilly
RFK Jr. to require placebo-controlled studies for new vaccines
NPR
Thursday, May 1, 2025 - 10:18pm
tags:
Robert F Kennedy Jr., vaccines, clinical trials, placebos
Concentra acquires struggling small-molecule biotech Kronos
Fierce Biotech
Thursday, May 1, 2025 - 10:16pm
tags:
Concerta, Kronos Bio, M&A
Immunic presses ahead with MS drug despite Phase II endpoint miss
Clinical Trials Arena
Thursday, May 1, 2025 - 10:15pm
tags:
Immunic, MS, vidofludimus calcium, clinical trials, multiple sclerosis

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.